1548 — Genscript Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapNeutral

Annual balance sheet for Genscript Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,403	1,463	1,928	621	812
Net Total Accounts Receivable
Net Total Receivables	167	171	300	136	134
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,639	1,765	2,353	835	1,079
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	505	647	751	603	623
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,234	2,546	3,387	5,278	4,853
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	413	546	495	307	720
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,188	1,536	1,996	957	894
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,046	1,011	1,391	4,321	3,959
Total Liabilities & Shareholders' Equity	2,234	2,546	3,387	5,278	4,853
Total Common Shares Outstanding